How might the mood of a patient be affected who has had spell‑like episodes for 18 months progressing to seizures, a recent EMU (electro‑encephalographic monitoring unit) study favoring functional neurological disorder (FND) or psychogenic non‑epileptic seizures (PNES) over epilepsy, a right posterior frontal‑parietal meningioma abutting the superior sagittal sinus, and a history of night terrors?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Mood Impact in FND/PNES with Comorbid Meningioma and Night Terrors

This patient's mood is likely significantly impaired through multiple converging mechanisms: the psychological distress inherent to FND/PNES (particularly with trauma-related night terrors), the chronic uncertainty and disability from 18 months of progressive seizure-like episodes, potential direct neurological effects from the right posterior frontal-parietal meningioma, and the compounding anxiety of diagnostic ambiguity.

Primary Mood Considerations

FND/PNES-Related Mood Burden

The EMU findings favoring FND/PNES over epilepsy carry substantial psychiatric implications. Patients with PNES consistently demonstrate worse mood outcomes than those with epileptic seizures, with point prevalence estimates showing 20.7% for mood disorders and 19.4% for adjustment disorders in similar populations 1.

The evidence reveals specific cognitive-emotional processing deficits in PNES patients 2:

  • Significantly lower clarity of emotions (mean score 37.5 vs. normative data, p<0.001)
  • Reduced ability to adjust to emotional states (mean score 22.2 vs. normative data, p<0.001)
  • These deficits correlate negatively with depression, anxiety, and stress severity

Trauma and Night Terror Component

The history of night terrors associated with spell onset is particularly concerning. Patients with PNES who have childhood trauma or active PTSD demonstrate significantly lower scores on emotion clarity, adjustment, and tolerance subscales than those without such histories (p<0.05) 2. The night terrors may represent:

  • Manifestation of underlying PTSD or trauma-related pathology
  • Part of an integrated biopsychosocial model where early trauma leads to progressive neurosensitivity presenting as combined dysthymia, alexithymia, PTSD, and FND 3

Meningioma Considerations

The right posterior frontal-parietal meningioma abutting the superior sagittal sinus adds complexity. While the EMU suggests FND/PNES, cognitive impairment is present in 90% of brain tumor patients and has large impact on quality of life 4. The tumor location could contribute to:

  • Mood disturbance through direct neurological effects
  • Heightened anxiety about the upcoming MRI and potential tumor growth
  • Diagnostic uncertainty (is the tumor contributing to symptoms?)

Specific Mood Manifestations to Assess

Current Mood State

Screen for 1:

  • Depression symptoms: Worry about disease (70% prevalence), relationships (77%), family well-being (74%), finances (63%)
  • Anxiety disorders: Most common mental health issue in chronic neurological conditions (17.9% prevalence)
  • Heightened stress: Associated with increased symptom distress and maladaptive coping

Chronic Psychological Symptoms

Beyond acute mood, evaluate 5:

  • Somatization: Chronic indicator strongly related to poor health-related quality of life
  • Emotional distress: More predictive of quality of life than current mood state alone
  • Alexithymia: Difficulty identifying and describing emotions, common in FND/PNES 3

Functional Impact

The 18-month progression creates 6:

  • High levels of distress and disability
  • Unemployment or work difficulties
  • Social care utilization needs
  • Reduced quality of life
  • Stigma burden from the diagnosis

Critical Pitfalls

Do not assume mood symptoms are "just" reactive to the diagnosis. The evidence shows FND/PNES involves fundamental alterations in cognitive-emotion processing that require specific therapeutic targeting 2.

Do not overlook the bidirectional relationship: While mood disorders commonly co-occur with FND/PNES, the seizure-like episodes themselves may be exacerbating pre-existing depressive symptoms, creating a vicious cycle 7.

Do not dismiss the night terrors as incidental. They may represent core trauma-related pathology requiring specific treatment 8, 9. Nightmare disorder causes mood disturbance, sleep resistance, cognitive impairments, and behavioral problems that compound the overall clinical picture.

Management Implications

Immediate Assessment Priorities

  1. Formal psychiatric evaluation using validated tools (MADRS, NDDI-E for depression; anxiety screening)
  2. Trauma history assessment given night terrors and their association with worse FND/PNES outcomes
  3. Cognitive-emotional processing evaluation (emotion clarity, adjustment capacity)
  4. Quality of life and functional disability measures 10

Treatment Framework

Education is foundational 6. The patient needs to understand:

  • FND/PNES represents genuine neurological symptoms caused by reversible miscommunication between brain and body
  • Diagnosis is made by positive clinical signs (not exclusion)
  • Self-directed attention worsens symptoms; redirecting attention can temporarily reduce them
  • The body's stress response influences nervous system functioning

Multidisciplinary rehabilitation should include 6:

  • Occupational therapy for functional rehabilitation and self-management strategies
  • Psychological therapy addressing trauma (if present) and cognitive-emotional processing deficits
  • Specific nightmare treatment if night terrors persist (Image Rehearsal Therapy has Level 1 evidence) 9

Medication Considerations

Levetiracetam, if prescribed for seizure management, carries psychiatric side-effect concerns 4. Monitor closely for mood deterioration, as this is the first-choice anticonvulsant in neuro-oncology settings but can worsen psychiatric symptoms in some patients.

Avoid benzodiazepines for anxiety management given seizure-like presentation and risk of dependence 1.

References

Guideline

occupational therapy consensus recommendations for functional neurological disorder.

Journal of Neurology, Neurosurgery and Psychiatry, 2020

Guideline

position paper for the treatment of nightmare disorder in adults: an american academy of sleep medicine position paper.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2018

Guideline

best practice guide for the treatment of nightmare disorder in adults.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.